Overview - The company announced a supplementary notice regarding the payment of guarantee fees to related parties and the associated transactions [1] Transaction Details - The board of directors approved a proposal for the company to pay guarantee fees to related parties, which will be submitted for review at the 2024 annual general meeting [1] - The company’s wholly-owned subsidiary, Guizhou Daqin Tumor Hospital Co., Ltd., will receive a fixed asset loan from the Agricultural Development Bank of China, with guarantees provided by Guizhou Chitianhua Group and Zunyi Tiantong Plastic Co., Ltd. [1] - The guarantee fee payment is based on the assessed value of the collateral provided for the loan [2] Asset Evaluation - The assessed value of the collateral, which includes 66 properties and commercial spaces, is determined to be 200.8363 million yuan, reflecting a decrease of 22.23% from the previous bank assessment [2] - The decline in assessed value is attributed to reduced usable life of the assets and a sluggish real estate market [2] Adjusted Guarantee Fee Structure - The pricing basis for the guarantee fee will be adjusted according to the new assessed value [3] - The maximum estimated total guarantee fee is now capped at 34.6443 million yuan, calculated based on the new assessed value over a maximum period of 11.5 years [5] Future Implications - The adjustment in the assessed value of the collateral will lead to a reduction in the guarantee fees payable by the company [5] - The company aims to negotiate with the Agricultural Development Bank to release the guarantees by 2028, contingent on the hospital's operational performance [5]

Core Viewpoint - The evaluation of fixed assets, specifically buildings and structures owned by Guizhou Chitianhua Group Co., Ltd., is set for April 30, 2025, with detailed assessments provided for various properties [1][2][3][4][5][6]. Group 1: Asset Evaluation Details - The evaluation includes multiple properties such as factories, offices, and other facilities located in the Chishui City Chemical Road area, with ownership attributed to Guizhou Chitianhua Group Co., Ltd. [1][2][3]. - The assessment lists the original value, net value, and estimated value of each property, along with their respective construction dates and structural types [1][2][3][4]. - The total assessed value of the properties is approximately 133,062,800.00 RMB, with a detailed breakdown of individual properties and their respective values [6]. Group 2: Property Characteristics - Properties include various types of buildings such as factories, offices, and service facilities, with specific details on their construction area and rights [1][2][3][4]. - The evaluation also notes the age and condition of the buildings, indicating the depreciation and appreciation rates for each asset [1][2][3]. - The properties are primarily located in the Chishui City area, with specific land use rights documented for each asset [1][2][3][4].

Core Viewpoint - Guizhou Chitianhua Co., Ltd. reported a challenging financial year for 2024, with a net loss attributed to various operational factors, despite some growth in revenue from its chemical and medical service segments [1][2][3]. Financial Performance - The company achieved operating revenue of CNY 238,006.12 million in 2024, with a net loss attributable to shareholders of CNY -8,669.35 million [1][19]. - The chemical segment generated revenue of CNY 226,020.86 million, contributing a net profit of CNY 13,086.61 million, while the medical services segment reported a revenue of CNY 10,430.55 million with a net loss of CNY -12,867.21 million [1][3]. - The coal segment saw an increase in production and sales, with a slight rise in prices compared to the previous year [1]. Asset and Liability Overview - As of December 31, 2024, total assets amounted to CNY 483,556.81 million, reflecting a 2.58% increase from the beginning of the year [2][20]. - The company's debt ratio rose to 47.37%, an increase of 3.57% from the previous year [2]. Production and Sales Data - The company sold 66.11 million tons of urea, a year-on-year increase of 6.36%, and 32.81 million tons of methanol, up 46.16% [2][29]. - The production of synthetic ammonia, methanol, and urea increased by 7.06%, 42.36%, and 7.98% respectively compared to the previous year [3][29]. Future Outlook - For 2025, the company plans to produce 55.80 million tons of urea and 30 million tons of methanol, with a projected total revenue of CNY 217,830.13 million and a net loss of CNY -7,118.09 million [9][33]. - The company anticipates challenges due to market fluctuations in commodity prices, particularly for urea and methanol, which are influenced by international and domestic conditions [34].

本资产评估报告依据中国资产评估准则编制 贵州赤天化股份有限公司拟审议 支付担保费用所涉及的其指定 房地产的市场价值 餐产评估报告 中天华资评报字[2025]黔第1031号 (共一册,第一册) 北京中う 限责任公司 -- the state of the same of the with the state 中国资产评估协会 资产评估业务报告备案回执 | 报告编码: | 5211020122521301202500030 | | --- | --- | | 合同编号: | 中天华合同字[2025]黔P033号 | | 报告类型: | 非法定评估业务资产评估报告 | | 报告文号: | 中天华资评报字[2025]黔第1031号 | | 报告名称: | 贵州赤天化股份有限公司拟审议支付担保费用所涉及的其指定房 地产的市场价值资产评估报告 | | 评估结论: | 200,836,300.00元 | | 评估报告日: | 2025年05月08日 | | 评估机构名称: | 北京中天华资产评估有限责任公司 | | 签名人员: | 邓泽华 (资产评估师) 正式会员 编号:52000209 | | | 余颖莉 (资产评估师) ...

证券代码：600227 证券简称：赤 天 化 公告编号：2025-035 贵州赤天化股份有限公司 关于向关联方支付担保费暨关联交易的补充公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、情况概述 2025 年 4 月 28 日，贵州赤天化股份有限公司（以下简称：公司）召开了第 九届十五次董事会会议，审议通过了《关于向关联方支付担保费暨关联交易的议 案》，并提交公司 2024 年年度股东大会审议。贵州赤天化集团有限责任公司（以 下简称：赤天化集团）及贵州赤天化集团遵义天通塑料有限责任公司（以下简称： 天通公司）为公司全资子公司贵州大秦肿瘤医院有限公司（以下简称：大秦医院） 向中国农业发展银行清镇市支行（以下简称：农业发展银行）固定资产贷款提供 抵押担保，大秦医院拟向关联方支付担保费（以下简称：本次交易）。具体内容 详见公司 2025 年 4 月 29 日在《中国证券报》《上海证券报》和《证券时报》以 及上海证券交易所网站(www.sse.com.cn)上披露的《贵州赤天化股份有限公司关 于向关联方支付担保费暨关联交易公告 ...

贵州赤天化股份有限公司 GUIZHOU CHITIANHUA CO.,LTD. 2024 年年度股东大会 会议资料 二〇二五年五月 贵州赤天化股份有限公司 2024 年年度股东大会会议资料 贵州赤天化股份有限公司 2024 年年度股东大会现场会议议程 会议时间：2025 年 5 月 19 日下午 14:00 会议地点：贵州省贵阳市阳关大道 28 号赤天化大厦 22 楼会议室 主 持 人：董事长丁林洪 | 序号 | 会 议 议 程 | 资料 页码 | | --- | --- | --- | | 1 | 宣布大会开幕 | - | | 2 | 宣布到会股东人数及代表股份数 | - | | 3 | 审议《2024 年度董事会工作报告》 | 1 | | 4 | 审议《2024 年度监事会工作报告》 | 6 | | 5 | 年年度报告》及报告摘要 审议《2024 | 10 | | 6 | 审议《2024 年度财务决算方案》 | 11 | | 7 | 年度利润分配及资本公积金转增股本方案》 审议《2024 | 19 | | 8 | 审议《2025 年度财务预算方案》 | 20 | | 9 | 审议《关于公司为子公司、孙公司 ...

证券代码：600227 证券简称：赤天化 编号：2025-034 贵州赤天化股份有限公司 关于提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●被担保人名称及是否为上市公司关联人：被担保人贵州大秦肿 瘤医院有限公司（以下简称"大秦医院"）和贵州赤天化桐梓化工有 限公司（以下简称"桐梓化工"）系公司的全资子公司。 ●本次担保金额及已实际为其提供的担保余额：①2025年4月， 公司对大秦医院增加担保金额为996.5万元，截止至2025年4月30日， 公司累计为大秦医院提供担保余额为62,089.94万元；②2025年4月， 公司对桐梓化工增加担保金额为1,200万元，截止至2025年4月30日， 公司累计为桐梓化工提供担保余额为51,145万元；2025年4月，公司 提供担保的子公司归还借款金额5,972万元，截止至2025年4月30日， 公司及公司控股子公司对外担保总额为113,234.94万元，对外担保均 为公司为报表合并范围内的子公司提供的担保。 ●本次担保是否有反担保：否 ●对外担保逾期 ...

Core Viewpoint - Guizhou Chitianhua Co., Ltd. is set to participate in the "2025 Guizhou District Investor Collective Reception Day and 2024 Annual Performance Presentation" to enhance communication with investors and address their inquiries regarding the company's performance and strategies for 2024 [1][3]. Group 1: Event Details - The event is scheduled for May 12, 2025, from 15:40 to 17:40 [2][3]. - The meeting will be conducted online via the "Panorama Roadshow" platform [2][4]. - Investors can participate by logging into the specified website during the event time [4][6]. Group 2: Participation and Interaction - The company encourages investors to submit questions from the announcement date until May 8, 2025, through the WeChat account "Guizhou Capital Market" [2][6]. - The company will address commonly asked questions during the performance presentation [6]. Group 3: Attendees - Key personnel attending the meeting include Chairman and General Manager Ding Linhong, Independent Director Fan Qiyong, Executive Vice General Manager Gao Minhong, Board Secretary and Vice General Manager Xian Zhenghong, and Financial Director Ye Yong [5]. Group 4: Contact Information - For further inquiries, investors can contact Zhong Peijun at 0851-84396315 or via email at zqb@gzcth.net [7].

活动召开地点： "全景路演"（网址： http://rs.p5w.net） 活动召开方式：网络远程方式。投资者可在上述召开时间，通 过"全景路演"（网址： http://rs.p5w.net），在线参与本次活动， 公司将及时回答投资者的提问。 投资者可于本公告发出之日起至 2025 年 5 月 8 日，通过微信 关注"贵州资本市场"公众号，发送关键词"提问"，即可进入专区 提问。公司将在本次说明会上对投资者普遍关注的问题进行回答。 贵州赤天化股份有限公司（以下简称：公司）已于 2025 年 4 月 29 日在上海证券交易所网站（http://www.sse.com.cn）上披露了 证券代码：600227 证券简称：赤 天 化 编号：2025-033 贵州赤天化股份有限公司 关于参加"2025 年贵州辖区投资者集体接待日暨 2024 年度业绩说明会"并征集问题的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 活动召开时间：2025 年 5 月 12 日（周一）下午 15:40-17:40 （一）投资者可在 ...

Financial Performance - The company reported a basic earnings per share of -0.0512 yuan for 2024, an improvement of 27.27% compared to -0.0704 yuan in 2023 [1] - The net profit for 2024 was -0.87 billion yuan, showing a 26.89% increase from -1.19 billion yuan in 2023 [1] - Operating revenue increased by 5.97% to 23.8 billion yuan in 2024, up from 22.46 billion yuan in 2023 [1] - The return on equity improved to -3.34% in 2024 from -4.35% in 2023, marking a 23.22% change [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 31,886.8 million shares, accounting for 24.96% of the circulating shares, a decrease of 1,981.64 million shares from the previous period [2] - Notable shareholders include: - Changcheng Guorong Investment Management Co., Ltd. with 9,566.04 million shares (7.49% of total shares) [3] - China Great Wall Asset Management Co., Ltd. with 9,433.96 million shares (7.38% of total shares) [3] - Guizhou Yuyang Trading Co., Ltd. decreased its holdings by 57.97 million shares [3] Dividend Distribution - The company has announced no distribution or capital increase for the current period [2]